AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
At close: Sep 25, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $27.16 million as of September 29, 2025. Its market cap has increased by 767.34% in one year.
Market Cap
27.16M
Enterprise Value
27.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has increased from 20.42M to 27.16M, an increase of 33.02%. That is a compound annual growth rate of 8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 24.11M | 374.27% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 387.17M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |